In this course, the risk of developing ocular disease secondary to myopia are reviewed. Attendees will then learn the most relevant recent science on prescribing atropine, multifocal contact lenses, MiSight, atropine, and future treatment options. In addition to best practices in prescribing these myopia management modalities, a review of potential side effects, complications, and follow-up regimens will be reviewed.

Speaker: Ariel Cerenzie, O.D.

Date: Thursday, July 18, 2024

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

This event is undergoing COPE approval for 1 hour of CE credit.

Thank you to CooperVision for exhibiting at this event.